Multifocals: Careful pre-op preparation minimises explantation

Article

Careful patient selection and precise biometry will all help minimise the risk of later explantation of multifocal IOLs.

Careful patient selection and precise biometry will all help minimise the risk of later explantation of multifocal IOLs, Dr Risto Uusitalo of the Helsinki Eye Clinic said.

"There is a stacking effect, where a number of small errors stack up into a large error. That is why it is vital to get precise biometry, and select appropriate patients," explained Dr Uusitalo.

Exclusion criteria include astigmatism greater than 1.0 D, pre-existing ocular pathology, such as very dense cataract where you can't see the fundus properly, and previous refractive procedure. Physical data is not enough, assessing the psychological profile is also vital.

"A teacher once told me, if your patient has more than three pens in his pocket, be careful. They are typically physicians, architects, engineers and artists. They are perfectionists, they have unrealistic expectations and they are less likely to be happy with loss in vision quality," Dr Uusitalo said.

Similarly, professions that depend on the quality of vision should be excluded too, for example truck drivers.

Dr Uusitalo concluded that multifocal IOLs pose some risks that cannot be ignored, these can, however, be reduced and, overall, the benefits outweigh the risk, for the right patient.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.